Unknown NA INTERVENTIONAL 1-arm NCT01478516

Autologous Plasmin and Fibrinolytic System in Diabetic Retinopathy

Autologous Intravitreal Plasmin and Fibrinolytic System of Vitreous in Patient With Macular Edema

Sponsor: Hallym University

Updated 6 times since 2017 Last updated: Dec 1, 2011 Started: Nov 30, 2011 Primary completion: Nov 30, 2012 Completion: Nov 30, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01478516, this NA trial focuses on Macular Edema and remains ongoing. Sponsored by Hallym University, it has been updated 6 times since 2011, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Unknown NA
Sep 2024 — Sep 2025 [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status NA
Jun 2018 — Jan 2021 [monthly]

Unknown Status NA

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Unknown Status NA

First recorded

Nov 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hallym University
Hallym University Medical Center

Data source: Hallym University Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Chuncheon, South Korea